1887

Abstract

T-cell recognition of the secreted and membrane-bound portions of the herpes simplex virus type 2 (HSV-2) glycoprotein G (sgG-2 and mgG-2, respectively) was compared in symptomatic and asymptomatic HSV-2-infected individuals and in HSV-2-seronegative controls and the responses with HSV-1 glycoproteins C and E (gC-1 and gE-1) were compared. CD4 T cells from HSV-2-infected individuals specifically recognized both sgG-2 and mgG-2, whereas HSV-1-infected and HSV-seronegative controls did not respond to these glycoproteins. The responses to gC-1 and gE-1, on the other hand, were not type specific, as blood mononuclear cells from both HSV-1- and HSV-2-infected individuals responded . There was an association between the status of the infection (symptomatic versus asymptomatic) and the CD4 T-cell responsiveness. Symptomatic HSV-2-seropositive individuals responded with significantly lower Th1 cytokine production to sgG-2 and mgG-2 than did asymptomatic HSV-2-infected carriers, especially within the HSV-1-negative cohort. No differences in T-cell proliferation were observed between asymptomatic and symptomatic individuals. The results have implications for studies of HSV-2-specific CD4 T-cell reactivity in general and for analysis of immunological differences between asymptomatic and symptomatic individuals in particular.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.79978-0
2004-08-01
2020-10-01
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/8/vir852139.html?itemId=/content/journal/jgv/10.1099/vir.0.79978-0&mimeType=html&fmt=ahah

References

  1. Ahmed H. J., Mbwana J., Gunnarsson E., Ahlman K., Guerino C., Svensson L., Mhalu F., Lagergard T. 2003; Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two Tanzanian cities. Sex Transm Dis 30:114–119 [CrossRef]
    [Google Scholar]
  2. Augenbraun M., Feldman J., Chirgwin K., Zenilman J., Clarke L., DeHovitz J., Landesman S., Minkoff H. 1995; Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 123:845–847 [CrossRef]
    [Google Scholar]
  3. Balachandran N., Hutt-Fletcher L. M. 1985; Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J Virol 54:825–832
    [Google Scholar]
  4. Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M., Sacks D. L. 2002; CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502–507 [CrossRef]
    [Google Scholar]
  5. Bergström T., Sjögren-Jansson E., Jeansson S., Lycke E. 1992; Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies. Mol Cell Probes 6:41–49 [CrossRef]
    [Google Scholar]
  6. Biron C. A., Byron K. S., Sullivan J. L. 1989; Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735 [CrossRef]
    [Google Scholar]
  7. Burchett S. K., Corey L., Mohan K. M., Westall J., Ashley R., Wilson C. 1992; Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 165:813–818 [CrossRef]
    [Google Scholar]
  8. Carmack M. A., Yasukawa L. L., Chang S. Y., Tran C., Saldana F., Arvin A. M., Prober C. G. 1996; T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J Infect Dis 174:899–906 [CrossRef]
    [Google Scholar]
  9. Cauda R., Laghi V., Tumbarello M., Ortona L., Whitley R. J. 1989; Immunological alterations associated with recurrent herpes simplex genitalis. Clin Immunol Immunopathol 51:294–302 [CrossRef]
    [Google Scholar]
  10. Ching C., Lopez C. 1979; Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun 26:49–56
    [Google Scholar]
  11. Cunningham A. L., Turner R. R., Miller A. C., Para M. F., Merigan T. C. 1985; Evolution of recurrent herpes simplex virus lesions. J Clin Invest 75:226–233 [CrossRef]
    [Google Scholar]
  12. Dall'Olio F., Malagolini N., Campadelli-Fiume G., Serafini-Cessi F. 1987; Glycosylation pattern of herpes simplex virus type 2 glycoprotein G from precursor species to the mature form. Arch Virol 97:237–249 [CrossRef]
    [Google Scholar]
  13. de la Calle-Martin O., Hernandez M., Ordi J. 7 other authors 2001; Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J Clin Invest 108:117–123 [CrossRef]
    [Google Scholar]
  14. de la Salle H., Zimmer J., Fricker D. 8 other authors 1999; HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 103:R9–R13 [CrossRef]
    [Google Scholar]
  15. Forsgren M., Skoog E., Jeansson S., Olofsson S., Giesecke J. 1994; Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 5:113–116
    [Google Scholar]
  16. Frenkel L. M., Garratty E. M., Shen J. P., Wheeler N., Clark O., Bryson Y. J. 1993; Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 118:414–418 [CrossRef]
    [Google Scholar]
  17. Görander S., Svennerholm B., Liljeqvist J.-Å. 2003; Secreted portion of glycoprotein G of herpes simplex virus type 2 is a novel antigen for type-discriminating serology. J Clin Microbiol 41:3681–3686 [CrossRef]
    [Google Scholar]
  18. Harandi A. M., Svennerholm B., Holmgren J., Eriksson K. 2001; Differential roles of B cells and IFN- γ secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol 82:845–853
    [Google Scholar]
  19. Heise M. T., Virgin H. W. IV 1995; The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 69:904–909
    [Google Scholar]
  20. Kinghorn G. R. 1994; Epidemiology of genital herpes. J Int Med Res 22 (Suppl. 1):14A–23A
    [Google Scholar]
  21. Koelle D. M., Wald A. 2000; Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 45 (Suppl. T3):1–8
    [Google Scholar]
  22. Koelle D. M., Corey L., Burke R. L., Eisenberg R. J., Cohen G. H., Pichyangkura R., Triezenberg S. J. 1994; Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol 68:2803–2810
    [Google Scholar]
  23. Koelle D. M., Frank J. M., Johnson M. L., Kwok W. W. 1998a; Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol 72:7476–7483
    [Google Scholar]
  24. Koelle D. M., Posavad C. M., Barnum G. R., Johnson M. L., Frank J. M., Corey L. 1998b; Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest 101:1500–1508 [CrossRef]
    [Google Scholar]
  25. Koelle D. M., Schomogyi M., Corey L. 2000a; Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection. J Infect Dis 182:662–670 [CrossRef]
    [Google Scholar]
  26. Koelle D. M., Schomogyi M., McClurkan C., Reymond S. N., Chen H. B. 2000b; CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. J Virol 74:11422–11425 [CrossRef]
    [Google Scholar]
  27. Kohl S., Loo L. S., Drath D. B., Cox P. 1989; Interleukin-2 protects neonatal mice from lethal herpes simplex virus type 2 infection: a macrophage-mediated, interferon-induced mechanism. J Infect Dis 159:239–247 [CrossRef]
    [Google Scholar]
  28. Koutsky L. A., Ashley R. L., Holmes K. K., Stevens C. E., Critchlow C. W., Kiviat N., Lipinski C. M., Wolner-Hanssen P., Corey L. 1990; The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 17:90–94 [CrossRef]
    [Google Scholar]
  29. Krone M. R., Wald A., Tabet S. R., Paradise M., Corey L., Celum C. L. 2000; Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 30:261–267 [CrossRef]
    [Google Scholar]
  30. Langenberg A., Benedetti J., Jenkins J., Ashley R., Winter C., Corey L. 1989; Development of clinical recognizable genital lesions among women previously identified as having “asymptomatic” herpes simplex virus type 2 infection. Ann Intern Med 110:882–887 [CrossRef]
    [Google Scholar]
  31. Langenberg A. G., Corey L., Ashley R. L., Leong W. P., Straus S. E. 1999; A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 341, 1432–1438 [CrossRef]
    [Google Scholar]
  32. Lee F. K., Coleman R. M., Pereira L., Bailey P. D., Tatsuno M., Nahmias A. J. 1985; Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 22:641–644
    [Google Scholar]
  33. Liljeqvist J.-Å., Trybala E., Svennerholm B., Jeansson S., Sjögren-Jansson E., Bergström T. 1998; Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol 79:1215–1224
    [Google Scholar]
  34. Liljeqvist J.-Å., Svennerholm B., Bergstrom T. 1999; Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. J Virol 73:9796–9802
    [Google Scholar]
  35. Liljeqvist J.-Å., Trybala E., Hoebeke J., Svennerholm B., Bergström T. 2002; Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J Gen Virol 83:157–165
    [Google Scholar]
  36. Marsden H. S., Buckmaster A., Palfreyman J. W., Hope R. G., Minson A. C. 1984; Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol 50:547–554
    [Google Scholar]
  37. Persson K., Månsson A., Jönsson E., Nordenfelt E. 1995; Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 27:195–199 [CrossRef]
    [Google Scholar]
  38. Posavad C. M., Koelle D. M., Shaughnessy M. F., Corey L. 1997; Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc Natl Acad Sci U S A 94:10289–10294 [CrossRef]
    [Google Scholar]
  39. Roizman B., Norrild B., Chan C., Pereira L. 1984; Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology 133:242–247 [CrossRef]
    [Google Scholar]
  40. Schacker T., Zeh J., Hu H. L., Hill E., Corey L. 1998; Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 178:1616–1622 [CrossRef]
    [Google Scholar]
  41. Siegal F. P., Lopez C., Hammer G. S. 11 other authors 1981; Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305:1439–1444 [CrossRef]
    [Google Scholar]
  42. Singh R., Kumar A., Creery W. D., Ruben M., Giulivi A., Diaz-Mitoma F. 2003; Dysregulated expression of IFN- γ and IL-10 and impaired IFN- γ -mediated responses at different stages in patients with genital herpes simplex virus-2 infection. Clin Exp Immunol 133:97–107 [CrossRef]
    [Google Scholar]
  43. Spatz M., Wolf H. M., Thon V., Gampfer J. M., Eibl M. M. 2000; Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons. J Med Virol 62:29–36 [CrossRef]
    [Google Scholar]
  44. Spruance S. L., Overall J. C. Jr, Kern E. R., Krueger G. G., Pliam V., Miller W. 1977; The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 297:69–75 [CrossRef]
    [Google Scholar]
  45. Su H. K., Eberle R., Courtney R. J. 1987; Processing of the herpes simplex virus type 2 glycoprotein gG-2 results in secretion of a 34,000-Mr cleavage product. J Virol 61:1735–1737
    [Google Scholar]
  46. Suri-Payer E., Amar A. Z., Thornton A. M., Shevach E. M. 1998; CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212–1218
    [Google Scholar]
  47. Suvas S., Kumaraguru U., Pack C. D., Lee S., Rouse B. T. 2003; CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198:889–901 [CrossRef]
    [Google Scholar]
  48. Svennerholm B., Olofsson S., Jeansson S., Vahlne A., Lycke E. 1984; Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol 19:235–239
    [Google Scholar]
  49. Trybala E., Liljeqvist J. Å., Svennerholm B., Bergström T. 2000; Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol 74:9106–9114 [CrossRef]
    [Google Scholar]
  50. Tunbäck P., Liljeqvist J.-Å., Löwhagen G.-B., Bergström T. 2000; Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies. J Gen Virol 81:1033–1040
    [Google Scholar]
  51. van Benthem B. H., Spaargaren J., van Den Hoek J. A., Merks J., Coutinho R. A., Prins M. 2001; Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 77:120–124 [CrossRef]
    [Google Scholar]
  52. Wald A., Zeh J., Selke S., Ashley R. L., Corey L. 1995; Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333:770–775 [CrossRef]
    [Google Scholar]
  53. Wald A., Corey L., Cone R., Hobson A., Davis G., Zeh J. 1997; Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 99:1092–1097 [CrossRef]
    [Google Scholar]
  54. Wald A., Zeh J., Selke S., Warren T., Ryncarz A. J., Ashley R., Krieger J. N., Corey L. 2000; Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342:844–850 [CrossRef]
    [Google Scholar]
  55. Wald A., Zeh J., Selke S., Warren T., Ashley R., Corey L. 2002; Genital shedding of herpes simplex virus among men. J Infect Dis 186 (Suppl. 1):S34–S39 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.79978-0
Loading
/content/journal/jgv/10.1099/vir.0.79978-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error